Antibodies to DNA. A perspective

Arthritis & Rheumatism

Volumn 29, Issue 12, 1986, Pages 1417-1426

  Emlen, Woodruff ^a,b,c   Pisetsky, David S ^a,b,c   Taylor, Ronald P ^a,b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b DUKE UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA ANTIBODY; MONOCLONAL ANTIBODY;

ADULT; ANTIGEN ANTIBODY COMPLEX; CLINICAL ARTICLE; DIAGNOSIS; DISEASE ACTIVITY; ETIOLOGY; HUMAN; JOINT; KIDNEY; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY COMPLEX; DNA; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0022894803     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780291201     Document Type: Article

References (82)

1. Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus
2. Immunological studies concerning the nephritis of systemic lupus erythematosus
3. Immunopathogenesis of systemic lupus erythematosus
4. Systemic lupus erythematosus: prototype of immune complex nephritis in man
5. Failure to detect circulating DNA‐anti‐DNA complexes by four radioimmunological methods in patients with systemic lupus erythematosus
6. The relation of immunoglobulin class, pattern of antinuclear antibody, and complement‐fixing antibodies to DNA in sera from patients with systemic lupus erythematosus
7. Measurement of serum DNA‐binding activity in systemic lupus erythematosus
8. Reassessment of the clinical significance of native DNA antibodies in systemic lupus erythematosus
9. Clinical significance of anti‐double‐stranded DNA antibodies detected by a solid phase enzyme immunoassay
10. Avidity of antibodies to dsDNA: comparison of IFT on Crithidia luciliae, Farr assay, and PEG assay
11. Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus
12. Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gammaglobulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis
13. Treatment of lupus nephritis in adult (NZB + NZW) Fl mice by cortisone‐facilitated tolerance to nucleic acid antigens
14. Suppression of NZB/NZW murine nephritis by administration of a syngeneic monoclonal antibody to DNA: possible role of anti‐idiotypic antibodies
15. Measurement of anti‐DNA antibodies
16. Immunology of DNA. V. Analysis of DNA/anti‐DNA complexes
17. Stability of DNA/anti‐DNA complexes. II. Salt lability and avidity
18. DNA‐anti‐DNA immune complexes: antibody protection of a discrete DNA fragment from DNAse digestion in vitro
19. Effect of antibody excess on the size, stoichiometry, and DNAse resistance of DNA anti‐DNA immune complexes
20. Stability of DNA/anti‐DNA complexes. IV. Complement fixation
21. Quantitative determination of anti‐dsDNA antibodies and antibody/dsDNA stoichiometries in prepared, soluble complement‐fixing antibody/dsDNA immune complexes
22. Studies of the physical biochemistry and complement‐fixing properties of DNA/anti‐DNA immune complexes
23. Reaction of systemic lupus erythematosus antinative DNA with native DNA fragments from 20 to 1200 base pairs
24. Specific concentration of polynucleotide immune complexes in the cryoprecipitates of patients with systemic lupus erythematosus
25. Detection of masked anti‐DNA antibodies in lupus sera by a monoclonal anti‐idiotype
26. DNA‐anti‐DNA complexes: their detection in systemic lupus erythematosus sera
27. 3H]‐dsDNA/anti‐DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess
28. Isolation of DNA from DNA/anti‐DNA antibody immune complexes in systemic lupus erythematosus
29. Circulating DNA in systemic lupus erythematosus
30. Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosus
31. Quantitation and characterization of plasma DNA in normals and patients with SLE
32. Binding of monoclonal anti‐native DNA autoantibodies to DNA of varying size and conformation
33. Clearance of circulating DNA‐anti‐DNA immune complexes in mice
34. Clearance of model DNA anti‐DNA immune complexes in mice (abstract)
35. Primate erythrocyte‐immune complex‐clearing mechanism
36. In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets
37. The kinetics of clearance of human antibody/dsDNA immune complexes from rabbit circulation: effects of dsDNA size, rheumatoid factor, and reduction and alkylation of the antibodies
38. Dynamics of interaction between complement‐fixing antibody/dsDNA immune complexes and erythrocytes: in vitro studies and potential general applications to clinical immune complex testing
39. Defective immune‐adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus
40. Defective reticuloendothelial system Fc‐receptor function in systemic lupus erythematosus
41. In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA: a possible basis for a local formation of DNA‐anti‐DNA complexes in systemic lupus erythematosus
42. Monoclonal anti‐DNA antibodies: an approach to studying SLE nephritis
43. Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus: comparison of antibodies in serum and renal eluates
44. Cross‐reactivity of anti‐DNA antibodies with proteoglycans
45. Characteristics of pathogenic subpopulations of antibodies to DNA
46. Glomerular localization of performed immune complexes prepared with anionic antibodies or with cationic antigens
47. The in vivo and in vitro glomerular deposition of isolated anti‐double‐stranded‐DNA antibodies in NZB/W mice
48. Distinct clonotypes of anti‐DNA antibodies in mice with lupus nephritis
49. Cross‐reactions of anti‐DNA antibodies and the central dogma of lupus nephritis
50. Monoclonal autoantibodies: an approach to studying autoimmune disease
51. Origins of anti‐DNA antibodies
52. Hybridoma SLE autoantibodies: insights for the pathogenesis of autoimmune disease
53. Generation of anti‐type III pneumococcal polysaccharide hybridomas from mice with an X‐linked B‐lymphocyte defect
54. Production of autoantibodies by human‐human hybridomas
55. Hybridoma anti‐DNA autoantibodies from patients with rheumatoid arthritis and systemic lupus erythematosus demonstrate similar nucleic acid binding characteristics
56. Production of monoclonal murine autoantibodies to DNA by somatic cell hybrids
57. Antigen‐binding diversity and idiotypic cross‐reactions among hybridoma autoantibodies to DNA
58. Anti‐DNA autoantibodies in (NZB X NZW) Fl mice are clonally heterogeneous, but the majority share a common idiotype
59. Polyspecificity of monoclonal lupus autoantibodies produced by human‐human hybridomas
60. Monoclonal antibodies recognize different parts of Z‐DNA
61. Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids
62. Multiple autoantigen binding capabilities of mouse monoclonal antibodies selected for rheumatoid factor activity
63. Binding of cytoskeletal proteins by monoclonal anti‐DNA lupus autoantibodies
64. A monoclonal anti‐DNA antibody also binds to cell‐surface protein(s)
65. Murine monoclonal anti‐DNA autoantibodies bind to endogenous bacteria
66. Specificity and idiotypic analysis of a monoclonal anti‐Sm antibody with anti‐DNA activity
67. Monoclonal anti‐cardiolipin antibodies bind to DNA
68. Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity
69. The B cell repertoire for autoantibodies: frequency of precursor cells for anti‐DNA antibodies
70. A high frequency idiotypic marker of anti‐DNA autoantibodies in MRL‐lpr/lpr mice
71. Normal mice express idiotypes related to autoantibody idiotypes of lupus mice
72. Murine monoclonal anti‐DNA antibodies with an absolute specificity for DNA have a large amount of idiotypic diversity
73. A public idiotypic determinant is present on spontaneous cationic IgG antibodies to DNA from mice of unrelated lupus‐prone strains
74. Expression of a highly conserved anti‐DNA idiotype in normal and autoimmune mice
75. Anti‐DNA autoantibody producing hybridomas of normal human lymphoid cell origin
76. In vitro production of an anti‐DNA idiotype by lymphocytes of normal subjects and patients with systemic lupus erythematosus
77. Gamma‐M rheumatoid factors reacting with nitrophenyl groups and denatured deoxyribonucleic acid
78. Crossreactivity of antiphospholipids
79. Affinity purified anti‐cardiolipin and anti‐DNA antibodies
80. Quantitative aspects of lupus anti‐DNA autoantibody specificity
81. Base specificity and idiotypy of anti‐DNA autoantibodies reactive with synthetic nucleic acids
82. 125I‐labelled DNA‐binding test: elimination of nonspecific binding of DNA to non‐immunoglobulin basic proteins by using an anionic detergent